| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.078 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |